Sahajanand Medical Technologies IPO Subscription Status Day 1: Issue Subscribed 0.35 Times

Authored By HDFC SKY | Published at: Oct 15, 2026 05:43 PM IST

Sahajanand Medical Technologies IPO Day 1 subscription status stood at 0.35x overall as of October 15, 2026, with retail at 0.41x, QIB at 0.37x and NII at 0.20x.

Open Free Demat Account

Mumbai, October 15: The Sahajanand Medical Technologies IPO was subscribed 0.35 times overall on its first day of bidding, according to exchange data recorded at 5:04 PM on October 15, 2026. Retail investors subscribed 0.41 times their reserved portion, while the qualified institutional buyer (QIB) category, excluding anchor investors, recorded subscription of 0.37 times. Demand from non-institutional investors (NII) stood at 0.20 times. The ₹475.48 crore bookbuilding issue opened on October 15 and is scheduled to close on October 19, 2026. The IPO comprises an offer for sale of 1,38,22,116 shares. The price band is fixed at ₹327 to ₹344 per share, and the lot size is 43 shares. At the upper price band, the minimum retail investment is ₹14,792 for one lot.

Sahajanand Medical Technologies IPO Day 1 Subscription Status

As of 5:04 PM on October 15, 2026, the overall issue had received bids for 33,70,211 shares against 97,50,482 shares offered across the reported investor categories, excluding anchor investors. The exchange snapshot recorded 40,001 applications.The retail category recorded the highest subscription among the three main investor categories at 0.41 times, followed by QIBs at 0.37 times. The NII portion was subscribed 0.20 times. The employee category, against its reservation of 2,50,000 shares, recorded subscription of 0.08 times.

Subscription Category	Shares Offered	Shares Bid For	Subscription
QIB (Ex Anchor)	27,14,424	10,09,726	0.37x
NII/HNI	20,35,817	4,15,896	0.20x
Retail	47,50,241	19,23,906	0.41x
Employees	2,50,000	20,683	0.08x
Overall	97,50,482	33,70,211	0.35x

The cumulative subscription figures are based on the exchange snapshot updated at 5:04 PM on October 15, 2026.

Sahajanand Medical Technologies Day-wise Subscription Summary

The IPO opened for subscription on October 15, 2026. On Day 1, the issue was subscribed 0.35 times overall. Retail participation stood at 0.41 times, while QIBs recorded 0.37 times subscription. The NII category was subscribed 0.20 times.

Date	QIB (Ex Anchor)	NII	bNII (Above ₹10 Lakh)	sNII (Up to ₹10 Lakh)	Retail	Employees	Overall
October 15, 2026 (Day 1)	0.37x	0.20x	0.13x	0.36x	0.41x	0.08x	0.35x

Sahajanand Medical Technologies IPO Timeline

IPO Milestone	Date
Issue Open Date	October 15, 2026
Issue Close Date	October 19, 2026
Basis of Allotment Date	October 21, 2026
Initiation of Refunds	October 22, 2026
Credit of Shares	October 22, 2026
Listing Date	October 23, 2026

The basis of allotment is scheduled for October 21, 2026. Refunds and credit of shares are expected on October 22, followed by the tentative listing on the BSE and NSE on October 23, 2026.

Brief Overview Of The Sahajanand Medical Technologies IPO

Sahajanand Medical Technologies IPO is a ₹475.48 crore bookbuilding issue comprising an offer for sale of 1,38,22,116 shares. The issue opened on October 15 and will close on October 19, 2026. No fresh issue component is listed in the supplied IPO details. The price band is ₹327 to ₹344 per share, with a lot size of 43 shares. Retail investors can apply for a minimum of one lot, requiring an investment of ₹14,792 at the upper price band. The issue is scheduled to list on the BSE and NSE, with October 23, 2026, set as the tentative listing date. Motilal Oswal Investment Advisors Ltd. is the book-running lead manager, while MUFG Intime India Pvt. Ltd. is the registrar to the issue.

Source:

https://www.nseindia.com/market-data/issue-information?symbol=SMT&series=EQ&type=Active

Disclaimer

The information shared here is intended solely for informational and educational purposes and does not constitute investment recommendations. While we practice strict due diligence in curating daily market data, readers must perform independent research before trading. To flag any real-time data discrepancies or content concerns, please write to us at content@hdfcsec.com.

IPO